Gene · 10219
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Limited adaptability of virtual memory CD8 T cells to chronic viral infection. | Front Immunol | 2026 | 42254011 | PubTator, text mining | PubMed |
| Spatially microdissected profiling of tonsillar germinal centers reveals a KLRG1-enriched immune signature in IgA nephropathy. | Front Immunol | 2026 | 42253971 | PubTator, text mining | PubMed |
| Deep immunological resetting in refractory systemic lupus erythematosus post-kidney transplantation: A longitudinal immunophenotypic analysis. | Lupus | 2026 | 42246677 | PubTator, text mining | PubMed |
| miR-142-5p promotes TSCM differentiation and suppresses progressive T-cell maturation via targeting PRKCB. | Front Immunol | 2026 | 42233018 | PubTator, text mining | PubMed |
| Clinical-scale 10-day TCR-T cell manufacturing using IL-2/7/15 and TGF-β promotes early memory and tissue-resident-like phenotypes and robust antitumor activity in vitro. | Front Immunol | 2026 | 42220480 | PubTator, text mining | PubMed |
| Immune profile and mitochondrial alterations driven by age and HIV infection: Associations with T-cell senescence in people with HIV receiving suppressive antiretroviral therapy. | Virol Sin | 2026 | 42140386 | PubTator, text mining | PubMed |
| KLRG1 silencing increases the efficacy of CAR NK cell therapy against colon cancer via SHP-2/ZAP-70/NF-κB signal pathway. | J Transl Med | 2026 | 42135837 | PubTator, text mining | PubMed |
| Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis. | Ann Rheum Dis | 2026 | 42120292 | PubTator, text mining | PubMed |
| Multiple sclerosis-associated HLA demarcates EBV-specific CD8+ T cells with an exhausted and brain residency phenotype. | iScience | 2026 | 42111195 | PubTator, text mining | PubMed |
| Immunosenescence and Cancer: Cellular Aging Programs That Reshape Antitumor Immunity. | Immune Netw | 2026 | 42109610 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccination. | iScience | 2026 | 42095075 | PubTator, text mining | PubMed |
| Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers. | Ann Rheum Dis | 2026 | 42091395 | PubTator, text mining | PubMed |
| Association between T cell exhaustion and the recurrence of atrial fibrillation after cryoballoon ablation. | Front Immunol | 2026 | 42058192 | PubTator, text mining | PubMed |
| Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity. | Sci Adv | 2026 | 42018612 | PubTator, text mining | PubMed |
| Single cell analysis of neonatal naïve CD8α + T cells reveals novel subsets bridging the innate-adaptive spectrum. | bioRxiv | 2026 | 41959467 | PubTator, text mining | PubMed |
| Targeting the novel immune checkpoint KLRG1 is markedly therapeutic against cancer through multiple lymphocyte subsets. | J Immunother Cancer | 2026 | 41956544 | PubTator, text mining | PubMed |
| Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells. | Oncotarget | 2026 | 41954945 | PubTator, text mining | PubMed |
| IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression. | Inflamm Res | 2026 | 41917320 | PubTator, text mining | PubMed |
| Blimp-1 integrates alarmin signals in ILC2s and drives proinflammatory functions required for type 2 immunity. | J Exp Med | 2026 | 41915169 | PubTator, text mining | PubMed |
| ZFP148 is a transcriptional repressor of cytolytic effector CD8+ T cell differentiation. | Nat Immunol | 2026 | 41896465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10219/papers?page=2